Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kodak looks to gain US clearance for CR (computed radiography) digital mammography technology:

This article was originally published in Clinica

Executive Summary

Eastman Kodak is seeking US FDA marketing clearance to add mammography capabilities to its computed radiography (CR) technology. The optional feature, which was introduced earlier this year for use on the company's DirectView CR 850, CR 950 and CR 975 systems in Europe, Asia, Japan and Latin America, is designed to offer the sharp and detailed images required for mammography. Kodak said its submission with the FDA related to information on the manufacturing of its CR system and on analytical tests the system has undergone. The company is currently conducting clinical trials of its digital mammography system at several sites in the US and Canada.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058000

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel